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MI at 1 year was obtained by the GRACE RS but the performance of the PURSUIT and
TIMI RS was good. We found a statistically significant interaction between the risk strati-
fied by the best cut-off value for the GRACE and PURSUIT RS and myocardial revascu-
larization, with a prognostic benefit for the higher risk patients.
Conclusions: The risk scores studied demonstrated a good predictive accuracy for D or
MI at 1 year and allowed the identification of high risk subsets of patients that most bene-
fit from myocardial revascularization performed during the initial hospital stay. 
1098-78 Low Hemoglobin Predicts Worse Clinical Outcomes in 
Acute Coronary Syndromes
Marc S. Sabatine, David A. Morrow, Robert P. Giugliano, Sabina A. Murphy, Carolyn H. 
McCabe, C. Michael Gibson, Christopher P. Cannon, Elliott M. Antman, Eugene 
Braunwald, for the TIMI Study Group, Brigham and Women's Hospital, Boston, MA
Background: In acute coronary syndromes (ACS), anemia has the potential to worsen
myocardial ischemia by further compromising oxygen delivery. We sought to determine
the impact of anemia on clinical outcomes in a broad cohort of patients with ACS.
Methods: Data from 22,333 patients with STEMI and 17,547 patients with UA/NSTEMI
from the pooled TIMI trial databases were analyzed. Baseline hemoglobin (Hgb) levels
were categorized in 1 g/dl increments. Multivariable logistic regression was used to
adjust for age, sex, hypertension, diabetes, smoking, renal insufficiency, prior MI, prior
CHF, prior ASA, prior CABG, and index revascularization.
Results: Lower baseline Hgb levels were associated with greater evidence of acute myo-
cardial injury in both STEMI (higher rates of Killip class II-IV and LBBB, p<0.001 for each)
and UA/NSTEMI (higher rates of ST deviation and higher peak troponin, p<0.001 for
each). In STEMI, patients with lower baseline Hgb levels had higher mortality at 30 days
(p<0.001) and in UA/NSTEMI they had higher rates of death, MI, or recurrent ischemia
(p<0.001). These associations remained significant even after adjusting for potential con-
founders and the adjusted odds ratios and 95% confidence intervals are presented in the
Figure.
Conclusion: Low Hgb on admission is independently associated with worse outcomes in
patients with ACS. These findings suggest that efforts to raise Hgb may be beneficial in
this setting. 
1098-79 Renal Function Predicts Outcomes in Acute Coronary 
Syndromes: Insights From the CURE Trial
Matyas Keltai, Marcello Tonelli, Johannes F. Mann, Basil Lewis, Steven Hawken, Shamir 
Mehta, Nasser Lakkis, Salim Yusuf, Hungarian Institute of Cardiology, Budapest, 
Hungary, McMaster University, Hamilton, ON, Canada
Background: Chronic renal insufficiency (CRI) is associated with increased mortality in
coronary artery disease. The aim of this study was to assess the relationship between
various degree of renal insufficiency and prognosis in patients (pts) with acute coronary
syndromes (ACS) Additionally we assessed if benefit of clopidogrel treatment is modified
in pts with CRI.
Methods: In the CURE trial 12.253 patients (97.5 %) had a baseline serum creatinine
measurement at enrollment. From this measurement the glomerular filtration rate (GFR)
was estimated using the MDRD equation, and the outcomes of patients with and without
CRI were compared.
Results: 3262 patients (26.2 %) had a GFR < 60 ml/min, corresponding to at least mod-
erate CRI. Patients with CRI were significantly older (70.3 +9.5, versus 62.0 +11.0).
Among patients with CRI there were more females (53.8, versus 32.8 % in the group
without CRI), and significantly more hypertensives (70, versus 54.9 %), diabetics (29,
versus 20.3 %) and more patients with previous myocardial infarction (39.8, versus 29.5
%). Major vascular events (cardiovascular death/myocardial infarction/stroke) occured
more frequently in patients with CRI (GFR>60 - 8.6 %; GFR 30.1-60 - 14.4 %;GFR 0-30
25.5 %). A significant gradient was present in all secondary outcome measures relative
to GFR. The beneficial effect of adding clopidogrel to standard treatment of ACS was
similar and statistically significant in pts below and above the median value of GFR, with
no evidence of statistical heterogeneity (RR 0.83; 95 % CI:0.72-0.95, versus 0.73; 95 %
CI: 0.61-0.87). The risk of major/life-threatening bleeding was increased in patients with
CRI in the CURE trial population (2.1 versus 1.0 %), this risk only moderately increased
by adding clopidogrel, and the hazard ratio was similar in patients with CRI (HR 1.5 +
1.16 - 1.92) and without CRI (HR 1.14+ 0.83 - 1.59).
Conclusion: CRI carries a poor prognosis in pts with non ST elevation ACS. Adding clo-
pidogrel to standard treatment of ACS was safe and resulted in a decreased incidence of
major cardiovascular outcomes in patients with and without CRI .
1098-80 High-Normal Creatinine: An Underappreciated Predictor 
of Poor Outcomes in Chest Pain Patients
Charles A. Henrikson, David E. Bush, Eric E. Howell, Nisha Chandra-Strobos, Johns 
Hopkins Medical Institutions, Baltimore, MD
Background: Patients with renal insufficiency have poor outcomes following acute myo-
cardial infarction (MI) or unstable angina. However, little investigation has focused on the
impact of high-normal creatinine on clinical outcomes.
Methods: We prospectively followed 459 patients with ongoing chest pain admitted to the
hospital with suspected myocardial ischemia. Patients with elevated creatinine (>=1.4
mg/dL, n=58) were excluded.
Results: Patients with high-normal creatinine (1.0-1.3 mg/dL, n=129), compared to those
with low-normal creatinine (<1.0 mg/dL, n=272), tended to be male (66% v. 36%), hyper-
tensive (66% v. 52%), and older (62 +/-16 v. 55 +/- 15 yrs (mean+/-SD)) (all p<0.05), but
the rates of diabetes mellitus (24% v. 20%), high cholesterol (36% v. 44%), and MI at pre-
sentation (16% v. 10%) were similar (all p=NS). Among patients with high-normal creati-
nine, 22% (unadjusted) suffered a subsequent MI, revascularization, or death by 120
days. This compares to 13% in patients with low-normal creatinine (p<0.05). The Kaplan-
Meier curve, adjusted for baseline differences between the two groups, confirmed a
higher rate of subsequent MI, revascularization, or death in the high-normal creatinine
group as compared to the low-normal creatinine group, mainly attributable to an increase
in early events (p<0.05).
Conclusion: These data identify high-normal creatinine as an independent, albeit under-
appreciated, risk factor for poor outcomes in patients with suspected myocardial
ischemia.
1098-81 Which White Blood Cell Compartments Predict 
Increased Cardiovascular Risk?
Jerry M. John, Jeffrey L. Anderson, Benjamin D. Horne, Tami L. Bair, Kurt R. Jensen, 
Heath U. Jones, Dale G. Renlund, Joseph B. Muhlestein, LDS Hospital, Salt Lake City, 
UT, University of Utah, Salt Lake City, UT
Background: Epidemiological observations have associated an elevated white blood cell
(WBC) count with the development of cardiovascular disease, but which leukocyte com-
partments carry this risk is uncertain.
Methods: Patients entered into the Intermountain Heart Collaborative Study Registry
between 1994–2001 who had angiographic assessment of coronary artery disease
(CAD), a baseline total and differential WBC count, and long-term follow-up for death or
nonfatal myocardial infarction (MI) were studied. Patients (pt) with acute MI were
excluded from primary analyses. The predictive value for D/MI of total WBC, neutrophil
(N), lymphocyte (L), monocyte (M) counts, and N/L ratio was assessed using Cox regres-
sions.
Results: 3227 pt were studied. Mean age was 64; 62% were male; 53%, hypertensive;
45%, hyperlipidemic; 17%, smokers; 20%, diabetic. Time to event (N=478, 14.8%) or last
follow-up averaged 3.5 years. WBC total and compartment counts were non-normally
distributed. In univariate analysis, an increased hazard (HR) ratio was associated with
fourth (vs. first) quartile (Q) total WBC (1.4, p<0.01), N (2.0, p<0.001), L (0.41, p<0.001),
M (1.4, p<0.01), and N/L (2.7, p<<0.001) counts. In multivariable modeling (backward
conditional stepwise regression), entering standard risk factors, presentation, and CAD
severity, WBC (HR 1.4, p=0.01) and M (HR 1.3, p<0.02) were weaker and N (HR 1.8,
p<0.001), L (HR 0.51, p<0.001), and N/L (HR 2.2, p<0.001) were stronger independent
predictors of death/MI. When WBC variables were entered together, N/L was retained as
an independent predictor (HR 2.2, CI 1.7-2.9, p<<0.001), together with age, diabetes,
presentation, CAD severity, family history, and M (model chi-square 190). Risk associa-
tions persisted in analyses restricted to CAD pt or including acute MI pt.
Conclusions: Total WBC count is confirmed to be an independent predictor of D/MI in
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patients with or at high risk for CAD, but much greater predictive value is provided by high
N (4Q>6.6 x 103/µL) or low L counts. Optimal risk prediction is given by N/L ratio, with 4
vs. 1 Q (>4.71 vs. <1.96) ratio increasing hazard by 2.2 fold. These findings have impor-
tant implications for CAD prognosis and pathogenesis.
1098-82 Dynamic Modeling of ST Elevation Acute Myocardial 
Infarction: Insights From COMMA
Paul W. Armstrong, Wei-Ching Chang, Kenneth Mahaffey, Douglas Weaver, Judith 
Hochman, Pierre Theroux, Christopher B. Granger, The COMMA Investigators, 
University of Alberta, Edmonton, AB, Canada
Background: The dynamic nature of ST elevation (STE) myocardial infarction treated
with primary percutaneous coronary intervention (PCI) provides progressive opportuni-
ties to evaluate the likelihood of unfavorable outcomes.
Methods: We studied this phenomenon in COMMA (COMplement inhibition in Myocar-
dial infarction treated with Angioplasty) study of 814 patients with STEMI presenting
within 6 hours who received Pexelizumab (PEX) versus placebo. The 90-day composite
endpoint of death, shock, and congestive heart failure was 10.1%. Logistic regression
analysis was used to predict the 90-day composite outcome at baseline, 30 minutes after
primary PCI and 48-72 hours after randomization.
Results: Whereas age, Killip class, infarct location, and baseline QRS score prove to be
significant predictors at baseline, culprit infarct artery TIMI perfusion and the extent of ST
resolution (30 min after PCI) each added marginally to the precision of the model (c-index
increased from 0.80 to 0.81); by 48-72 hours CK infarct size (AUC) added further preci-
sion to the model with an excellent C-index of 0.86.Although there was a poor correlation
between infarct size assessed by CK MB vs QRS on the 24 h ECG the latter added addi-
tional value to the predictive capacity of the model.
Conclusion: Risk assessment updated continuously soon after STEMI improves prog-
nostic precision thereby enhancing the ability to further refine diagnostic and therapeutic
decisions. 
1098-83 Gender- and Age-Related Differences in the Prognostic 
Value of C-Reactive Protein in Patients With 
Angiographic Coronary Artery Disease
Lillian L. Khor, Joseph B. Muhlestein, John F. Carlquist, Benjamin D. Horne, Tami L. Bair, 
Jeffrey L. Anderson, Chloe A. Allen Maycock, Intermountain Heart Collaborative (IHC) 
Study Group, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT
Background: C-reactive protein (CRP), a circulating inflammatory marker, has been pro-
posed for primary and secondary coronary disease (CAD) risk prediction. Whether gen-
der and age affect its predictive value is unknown.
Methods: The study aim was to determine whether gender and age affect serum con-
centration and prognostic value of CRP. In a consecutive series of 2254 patients with
angiographically defined CAD, we compared baseline CRP levels and predictive value for
incident death (D) or non-fatal myocardial infarction (MI) by gender overall and by age
(<55 and >55 years). CRP was measured by fluorescence polarization immunoassay.
Patients were followed for a mean of 2.3 years. Comparisons used ln-transformed CRP
and linear and time-to-event regression analyses, adjusting for confounders.
Results: Overall, women had higher geometric mean (1.47 vs. 1.30 mg/dL) CRP than
men (p<0.001), which remained significant (p=0.002) after adjustment for age, hyperlipi-
demia, diabetes, prior MI, and heart failure. Overall, high CRP increased the hazard of D/
MI among men (adjusted hazard ratio [adj HR]=1.9, 95% confidence interval [CI]=1.5-
2.3) but not women (adj HR=1.0, CI=0.69-1.4), p=0.004 for gender*CRP interaction. In
younger patients (<55), CRP was similarly predictive in men and women (adj HR= 2.2 vs.
2.7, p-interaction=0.67), whereas in more elderly (>55), it remained predictive for men
(adj HR=1.8) but lost predictive value for (post-menopausal) women (adj HR=0.93),
p=0.007 for gender*CRP interaction. In predictive modeling for D alone, high CRP was a
univariate (HR 1.6, p=0.05) but not multivariate predictor (adj HR 1.06) in these older
women.
Conclusion: Although CRP is an important predictor of overall outcome (D/MI) in CAD
patients its prognostic value varies by gender and age. CRP is equally and highly predic-
tive in younger men and women but loses its predictive value in older (post-menopausal)
women. This gender-age interaction may have important implications for CRP patho-
physiology and secondary risk assessment. Whether hormone replacement or age-
related biological changes explain the differential predictive value of CRP in older women
is unknown and requires further investigation.
1098-84 Persistently Increased Platelet Reactivity Prestages 
Subsequent Cardiac Events After an Acute Coronary 
Event
Kelly L. Hayes, Mary Godaire, Burton E. Sobel, David J. Schneider, Fletcher Allen Health 
Care, Burlington, VT, University of Vermont, Burlington, VT
Background: We have determined previously that platelet reactivity stratified patients at
high and low risk of cardiac events both immediately after coronary intervention and from
1 to 6 months after the procedure. This study was designed to identify changes in platelet
reactivity and their prognostic implications in patients who sustain an acute coronary syn-
drome (ACS).
Methods: Platelet reactivity at the time of the index event and after 45, 90, and 180 days
was characterized in 41 patients presenting with ACS. The capacity of platelets to bind
fibrinogen in response to 0.2 µM ADP was determined with the use of flow cytometry.
Results: Patients were categorized into low and high reactivity groups defined at the time
of the index event by the median percentage of platelets capable of binding fibrinogen in
response to 0.2 µM ADP. Cardiac events (death, repeat revascularization or myocardial
infarction [MI]) occurred in 7 in the high reactive group and 3 in the low reactive group
(Chi-square, p=0.002). The prevalence of treatment with clopidogrel was 61% in the high
reactive group and 31% in the low reactive group. Patients with high platelet reactivity at
the time of the index event continued to exhibit highly reactive platelets at each subse-
quent evaluation. Patients with diabetes mellitus tended to have greater platelet reactivity
(p=0.057) and were more likely to require repeat revascularization, sustain an MI or die
(p=0.006).
Conclusions: Increased platelet reactivity at the time of ACS identifies patients prone to
exhibit increased platelet reactivity during follow-up and who are at increased risk of car-
diac events after 6 months.
1098-101 Risk Stratification in Unstable Angina/Non-ST Elevation 
Myocardial Infarction Using Plasma N-Terminal Pro-
Atrial Natriuretic Peptide, Troponin I and High-Sensitive 
C-Reactive Protein Levels
Rudolf Jarai, Nelly Jordanova, Robert Jarai, Wolfgang Woloszczuk, Johann Wojta, Kurt 
Huber, Wilhelminen Hospital, Vienna, Austria
Background: Previous studies have shown, that elevated N-terminal pro-atrial natriuretic
peptide levels (Nt-proANP) have a strong association with mortality and morbidity in UA/
NSTEMI. It has also been shown, that this association is independent of other known risk
factors like elevated troponin T, ST-segment depression, diabetes mellitus and conges-
tive heart failure. The aim of this study was to investigate whether Nt-proANP levels inde-
pendently of troponin I concentrations (TnI) or high sensitive C-reactive protein levels
(hsCRP) predict future cardiac events and whether the combination of these variables
improves risk stratification of patients with UA/NSTEMI.
Methods: Plasma levels of the Nt-proANP, TnI and hsCRP levels were determined in 120
consecutive patients with typical chest pain due to UA/NSTEMI and normal left ventricu-
lar function. The patients were categorized into four groups based on the number of ele-
vated biochemical markers at admission.
Results: Nt-proANP levels showed no significant correlation with the patients TnI (r=0,2;
p=0,64) or hsCRP levels (r=0,18; p=0,4). All three variables were strong predictors of 2-
years death in univariable analysis. The multivariable logistic regression analysis
adjusted for age, previous myocardial infarction, ST-changes, diabetes, hypertension,
hypercholesterolemia showed, that elevations in Nt-proANP (>1,94nmol/l), TnI (>0,15ng/
ml) and hsCRP (>1,5mg/dl) concentrations have significant independent association with
mortality (Odds ratio (OR); Nt-proANP: 6,6 p<0,05; TnI: 5,5 p=0,014; hsCRP: 5,6
p<0,05). The number of elevated biochemical markers was a strong predictor of mortality
(p<0,001) and composite endpoint death or myocardial infarction (p<0,0001) after 2
years.
Conclusion: Nt-proANP is an independent prognostic marker in UA/NSTEMI. The simul-
taneous measurement of Nt-proANP, TnI and hsCRP provides a simple scoring system
to assess patient´s risk in UA/NSTEMI.
Model/Variable n (%) χ2 OR (95% CI)
At Baseline 
(c-index: 0.80)
Age (ref: < 64)
65-74 y
>74 y
494(61)
174(21)
146(18)
53 1
2.73(1.43,5.21)
5.04(2.77,9.18)
Baseline QRS (ref: 0-1)
2-3
4-6
>7
228(28)
196(24)
222(27)
168(21)
25 1
1.14(0.44,2.99)
1.75(0.73,4.19)
4.32(1.88,9.96)
Killip (ref: Class 1) 691(85) 7 2.21(1.26,3.89)
MI Location (ref: Inferior) 186(23) 4 2.41(1.04,5.59)
30-Min Model (c-index: 0.81)
30 min ST res (ref: complete)
Partial
None
374(46)
227(28)
145(18)
7 1
1.17 (0.63,2.20)
1.90 (0.97,3.73)
TIMI Grade (ref: 3)
Grade 2
Grade 0-1
714(88)
64(8)
36(4)
5 1
1.64(0.74,3.64)
6.50(2.54,16.6)
At 24-72 hours (c-index: 0.86)
CK AUC
(ref: <2216)
2216 – 4527
4527 – 7450
>7450
213(26)
200(25)
200(25)
201(25)
49
1
1.62(0.54,4.85)
2.79(1.04,7.50)
10.4(4.21,25.6)
QRS score
(ref: 0-3)
4-6
7-9
>9
202(25)
190(23)
183(23)
160(20)
19
1
1.35(0.42,4.32)
2.29(0.78,6.73)
3.26(1.13,9.38)
